CN Patent

CN115197244B — [1,2,4]三嗪并[3,2-b][1,3,5]噻二嗪类衍生物及应用

Assigned to Shijiazhuang University · Expires 2023-07-07 · 3y expired

What this patent protects

本发明公开了通式I的2H，8H‑[1,2,4]三嗪并[3,2‑b][1,3,5]噻二嗪‑8‑酮类衍生物或其药学可接受的水合物、盐,包括其立体异构体或互变异构体，其中，式I中的R1和R2分别独立的为氢、甲基、卤素、羟基、甲氧基、乙酰基、丙酰基、硝基或烷氧基，本发明的2H，8H‑[1,2,4]三嗪并[3,2‑b][1,3,5]噻二嗪‑8‑酮类衍生物对有较好的抗菌作用，可用于制备抗菌剂。

USPTO Abstract

本发明公开了通式I的2H，8H‑[1,2,4]三嗪并[3,2‑b][1,3,5]噻二嗪‑8‑酮类衍生物或其药学可接受的水合物、盐,包括其立体异构体或互变异构体，其中，式I中的R1和R2分别独立的为氢、甲基、卤素、羟基、甲氧基、乙酰基、丙酰基、硝基或烷氧基，本发明的2H，8H‑[1,2,4]三嗪并[3,2‑b][1,3,5]噻二嗪‑8‑酮类衍生物对有较好的抗菌作用，可用于制备抗菌剂。

Drugs covered by this patent

chembl-chembl1200962 (CEFEPIME HYDROCHLORIDE)

Patent Metadata

Patent number: CN115197244B
Jurisdiction: CN
Classification: —
Expires: 2023-07-07
Drug substance claim: No
Drug product claim: No
Assignee: Shijiazhuang University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.